INVO News and Press, INVO BioScience Inc. From 09/28/23

INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET PR Newswire SARASOTA, Fla. , Sept. 28, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Co...

2023-08-15 10:17:36 ET Gainers: Delcath Systems ( DCTH ) +90% . Pharvaris ( PHVS ) +22% . ENDRA Life Sciences ( NDRA ) +14% . NeurAxis ( NRXS ) +12% . SomaLogic ( SLGC ) +12% . Losers: Design Therapeutics ( DSGN ) -6...

2023-08-14 22:50:26 ET INVO Bioscience, Inc. (INVO) Q2 2023 Earnings Conference Call August 14, 2023 16:30 ET Company Participants Robert Blum - Investor Relations Steve Shum - Chief Executive Officer Mike Campbell - Chief Operating and Vice President, Business D...

2023-08-14 16:20:17 ET INVO BioScience press release ( NASDAQ: INVO ): Q2 GAAP EPS of -$3.06 beats by $1.14 . Revenue of $0.32M (+128.6% Y/Y) misses by $0.13M . For further details see: INVO BioScience GAAP EPS of -$3.06 beats by $1.14, revenue of $0.32M ...

INVO Reports Second Quarter 2023 Financial Results PR Newswire Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla. , Aug. 14, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services ...

2023-08-11 09:45:11 ET Fertility company INVO Bioscience ( NASDAQ: INVO ) Friday announced the closing of its acquisition of Wisconsin Fertility Institute. INVO's stock had jumped 24% in March when it first announced the acquisition for $10M in cash and stock. INVO +...

INVO Closes Acquisition of Wisconsin Fertility Institute PR Newswire Transformational and accretive acquisition adds significant scale to INVO's current operations Contributes over $5 million in incremental annual revenue as well as positive net income a...

INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023 PR Newswire Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla. , Aug. 9, 2023 /PRNewswire/ -- INVO Bioscie...

INVO Bioscience Announces Closing of $4.5 Million Public Offering PR Newswire SARASOTA, Fla. , Aug. 8, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to...

2023-08-04 10:09:12 ET Gainers: Alector ( ALEC ) +22% . OraSure Technologies ( OSUR ) +21% . Amneal Pharmaceuticals ( AMRX ) +20% . iRhythm Technologies ( IRTC ) +20% . Natera ( NTRA ) +16% . Losers: Mesoblast ( MESO ) ...